Atlas›Domain XII · Complementary, energy & biofield›Guide 084
Guide XII-084

Consumer PEMF devices (BEMER)

Triesen, Liechtenstein
A 29 · L 62 · M 910 interventions in the Trinity explorer
Client cardCompare
[source: …] where a claim comes from[uncertain] not confirmed in a primary source[synthesis] the writer's reconstruction

Version followed: BEMER Therapy System Evo as described in BEMER Int. AG's own Instructions for Use (Collection ID 2590, Version 11, 06/2022, Canadian edition) and in the US FDA 510(k) summary K231368 (2023); other consumer pulsed electromagnetic field (PEMF) mats are covered only in general terms. The psychotherapist works alongside this method and does not use, sell, demonstrate, prescribe or recommend the device.

1. Introduction

BEMER is a brand of pulsed electromagnetic field (PEMF) device made by BEMER Int. AG (Triesen, Liechtenstein). The current Evo system pairs a controller with a full-body mat and smaller applicators; some versions add low-level light applicators. [source: BEMER IFU Evo; ostjob.ch BEMER job listing]

  • The manufacturer's model of change: BEMER says the PEMF signal "stimulate[s] microcirculation", meaning blood flow in the smallest vessels, and so improves the supply to tissues. [source: BEMER IFU Evo] Consumer PEMF marketing more widely often uses the words "energy", "frequency" or "cell charge". These are the sellers' claims, attributed to them and not stated here as fact.
  • Indications differ by jurisdiction:
    • The US clearance is narrow: "To temporarily increase local blood circulation in healthy leg muscles" and to stimulate healthy muscles to support muscle performance. [source: FDA K231368]
    • The Canadian and European Instructions for Use list wider adjunct uses, including impaired wound healing, degenerative musculoskeletal conditions, neuropathy, chronic fatigue and pain. They state that the therapy "cannot replace medically prescribed therapy". [source: BEMER IFU Evo]
    • This guide does not present the device as treating any disease. The claims above are the manufacturer's.
  • Who sells it: BEMER sells through "its own, widely branched direct sales" network of sales partners and national agencies. The company advertises for managers experienced in "Direktvertrieb, Network Marketing". Many devices therefore reach clients through a friend, relative, therapist or other practitioner who is also a sales partner. [source: ostjob.ch BEMER job listing]
  • Where a client meets it: at home, or in a practitioner's session (massage, chiropractic, equine and spa settings). Spa and hotel pages describe it as a wellness service. [source: hotelmj.pl spa page, marketing material; uncertain: secondary]
  • Why it matters to the psychotherapist: clients may raise these devices around chronic pain, fatigue, health anxiety, hope and control, money pressure, and relationships with sellers. The therapist's work is the conversation, not the device. [synthesis]

2. Framework

2a. The method as the manufacturer describes it

What a client experiences

  • For full-body use, the person lies on a flat applicator (a mat, or a strap laid on a bed) with the body centred on it.
  • For local use, a pad or applicator is held against a body area by hand or with a strap.
  • A touchscreen controller sets the mode. Sound signals and optional relaxation music may play.
  • The light applicators are placed near clean, dry skin, and eye protection is required near the face.
  • Settings, programmes and session timings are deliberately left out of this guide.

[source: BEMER IFU Evo]

Who uses it

  • The IFU is written for lay home users and for medically trained staff in clinic or outpatient settings.
  • The Canadian IFU allows users aged 14 and over (younger people only with supervision). The US-marked IFU states 18 and over.

[source: BEMER IFU Evo; manualslib copy of the Spanish-language US IFU, uncertain: third-party copy]

Contraindications the manufacturer states

  • Active medical implants, such as pacemakers or medication pumps; the IFU says electromagnetic forces can disrupt them.
  • Organ, cell, bone-marrow or stem-cell transplant recipients on immunosuppressive therapy.
  • Diagnosed deep-vein thrombosis (listed in the US IFU).
  • Light applicators are not to be used on mucous membranes or near the eyes.

[source: BEMER IFU Evo; manualslib copy of the US IFU, uncertain: third-party copy]

When the manufacturer advises a doctor's approval first

  • Pregnancy, uncontrolled seizure disorders, severe heart-rhythm disorders, "severe psychosis", unexplained fever, infections and tumour diseases.
  • Anticoagulants, antihypertensives, beta-blockers, high-dose corticosteroids or other ongoing prescriptions.
  • Photosensitising medicines with the light therapy.

[source: BEMER IFU Evo]

Reported side effects: very rare, short-lived changes in pulse or blood pressure. Skin reactions are possible with the light applicators and with applicator materials. [source: BEMER IFU Evo]

Regulatory status, one line each

  • US: cleared through 510(k), not approved. BEMER Classic/Pro-Set was cleared in 2017 (K151834) and the Therapy System Evo in 2023 (K231368), as a Class II "powered muscle stimulator" (21 CFR 890.5850, product code NGX), over the counter, for healthy muscles only. [source: FDA K231368; innolitics K151834 record]
  • EU/UK: the IFU describes the controller and most applicators as Class IIa medical devices and names a UK vigilance contact. [source: BEMER IFU Evo]
  • Other consumer PEMF mats: many are sold under general-wellness positioning. FDA's general-wellness policy, revised in January 2026, excludes disease claims and applies enforcement discretion rather than review. [source: Covington summary of FDA 2026 guidance] Whether a particular mat is cleared needs checking product by product. [uncertain: not verified]
  • Evidence: a 2026 systematic review of 7 RCTs of BEMER for musculoskeletal pain concluded that current evidence does not show it is more effective than sham or placebo. [source: Karcı et al. 2026]

2b. The psychotherapist's work alongside it

There are no phases of the device itself for the therapist to deliver. The therapist's work runs in four overlapping steps, inside ordinary sessions; it is not a separate course of treatment. [synthesis]

  1. Ask and record
    • When: at intake, and whenever pain, fatigue or a purchase comes up.
    • Goal: an accurate, non-judgemental picture of use.
    • Move on: once use, cost, source and medical involvement are known.
  2. Understand
    • Format: one to two sessions, or woven into ongoing work.
    • Goal: meaning, hopes, the client's explanatory model, and their relationship with the seller.
    • Move on: once the client can say what they hope for and how they will judge it.
  3. Decide and coordinate
    • Goal: an informed, values-based choice, with the client's doctor kept informed (with consent).
    • Move on: once the decision is documented, risk is screened, and any implant or pregnancy question has gone to the doctor.
  4. Review
    • When: at intervals the client chooses.
    • Goal: check the effect on mood, money, relationships and medical care.
    • Also: watch for escalation, such as more devices, upgrades or recruitment into selling.

Move straight to the risk response in 4.6 at any point if medical care is being delayed, a child is involved, or financial or recruitment pressure is significant.

3. Guiding principles

Each principle below is the therapist's own stance [synthesis unless a source is given].

  • Curiosity, not verdicts: ask what the device means and does for the client before forming a view. In practice, no eye-rolls and no sales talk.
  • Stay in scope: do not advise on device settings, purchase, implants or medicines. Route device and medical questions to the doctor or pharmacist.
  • Attribute claims: name claims as the manufacturer's ("the company says it improves microcirculation"). Do not adopt the claim and do not mock it.
  • Respect autonomy: the choice to buy or use belongs to the adult client. Your job is to inform and support the decision, not to make it.
  • Keep medical care first: if the device is replacing or delaying assessment or treatment, that becomes a clinical priority to raise openly.
  • Know the safety facts: know the manufacturer's own warnings well enough to prompt the client to check them with their doctor. That means active implants, transplant recipients on immunosuppressants, DVT, pregnancy, uncontrolled epilepsy, severe psychosis and listed medicines. [source: BEMER IFU Evo]
  • No conflict of interest: never sell, rent, refer for commission, or host demonstrations. If you or a colleague is a sales partner, declare it and keep it out of clinical work. [synthesis; ethics code not verified]
  • Watch the money and the relationships: direct-sales and network-marketing structures can mix friendship, family, faith or group belonging with purchases and recruitment. Explore this gently. [source: ostjob.ch BEMER job listing for the sales model; synthesis for the clinical stance]
  • Hope is clinical material: the wish for relief, energy or control is real and can be worked with, whatever the device does.
  • Somatic distress needs a frame: for persistent bodily symptoms or health anxiety, offer an established psychological approach (cross-ref Domain II) rather than debating the device.
  • Record clearly: note what the client uses, who supplied it, the medical advice given, the risk screen, and the decisions made.

4. Intervention inventory

Every item below is the psychotherapist's own work alongside the client's device use. The procedures are the author's synthesis from general psychotherapy practice. Device facts come from the sources cited. [synthesis; device facts: BEMER IFU Evo, FDA K231368]

4.1 Routine, non-judgemental inquiry and recording

  • Purpose: learn about device use that clients often do not mention. Use it at intake and whenever pain, fatigue, sleep, "energy", money or a new purchase comes up.
  • Steps:
    1. Normalise the question first: many people use wellness devices and supplements.
    2. Ask open questions: what the device is, how they got it (bought, rented, borrowed, or used at a practitioner's), roughly how often they use it, and what they hope it does.
    3. Ask who introduced it and whether that person sells it.
    4. Ask whether their doctor knows, and check the manufacturer's safety list without giving device advice. Do they have a pacemaker or other active implant? Have they had a transplant and take immunosuppressants? Have they had a blood clot? Are they pregnant? Do they have epilepsy? [source for the list: BEMER IFU Evo]
    5. Record the brand and model if known, the supplier relationship, the cost bracket if the client offers it, medical awareness, and any risk flags.
  • Example language (illustrative):
    • "Lots of people use mats, apps or gadgets for pain or energy. Is there anything like that you use?"
    • "How did you come across it? Does the person who introduced you sell it?"
    • "Does your GP know you're using it? The maker's own leaflet asks some people to check with their doctor first."
  • Watch for:
    • Shame or defensiveness, which can mean the client expects ridicule.
    • Minimising the cost.
    • It is working when the client talks openly and keeps updating you.

4.2 Exploring meaning, hopes, expectations and explanatory model

  • Purpose: understand what draws the client to the device. It may be relief, a sense of control, distrust of medicine, identity (an active, "natural" self-carer), or belonging to a community of users or sellers. Use this after 4.1, or when the device carries emotional weight.
  • Steps:
    1. Ask the client to explain in their own words how they understand it to work. Reflect it back, attributed ("so the idea is that it boosts circulation").
    2. Explore the history: what has and hasn't helped before, and experiences of being dismissed by clinicians.
    3. Name the hopes concretely: what would be different if it worked?
    4. Ask how they will know whether it is helping, and over what time frame. Let the client choose markers such as function, mood, sleep or pain diary.
    5. Link the meaning to the therapy goals, e.g. control after chronic illness, or loyalty to a friend who sells it.
  • Example language (illustrative):
    • "What made you decide to try it now?"
    • "If it did everything you hoped, what would you be doing that you can't do now?"
    • "How will you tell whether it's the mat, or other things changing at the same time?"
  • Watch for:
    • All-or-nothing hope, e.g. "this is my last chance".
    • Distrust of doctors that is spreading to all care.
    • Signs it is working: the client separates the hope from the evidence and holds both calmly.

4.3 Attributed, accurate information on claims and status

  • Purpose: help the client weigh claims when they ask what you think, or when a decision depends on facts. Give information; do not persuade.
  • Steps:
    1. Ask permission before sharing information.
    2. Separate the claim from its source: the company's leaflet, a seller's testimonial, or a regulator.
    3. If relevant, explain the regulatory terms plainly:
      • In the US, BEMER devices are 510(k)-cleared as Class II powered muscle stimulators for healthy muscles, which is not the same as "FDA-approved" for a disease. [source: FDA K231368]
      • The Canadian and European leaflets list wider adjunct uses and say the device does not replace medically prescribed therapy. [source: BEMER IFU Evo]
    4. If asked about evidence, give it in one line: a 2026 systematic review found no clear advantage over sham for musculoskeletal pain. [source: Karcı et al. 2026]
    5. Hand the question back to the client: "What do you make of that?"
  • Example language (illustrative):
    • "Would it help if I told you what the official listing says, then you can decide what to make of it?"
    • "The US clearance is for healthy leg muscles and circulation. The sales talk you heard sounds broader, so it may be worth asking your doctor about."
  • Watch for:
    • The information landing as an attack, a sign of a rupture risk (see 5).
    • Over-correcting into debate.
    • Signs it is working: the client asks their own questions of sellers or their doctor.

4.4 Values-based, informed decision support

  • Purpose: help the client make their own decision to buy, keep, rent, return or stop. Use it when a significant purchase or upgrade is pending, or when the device competes with medical care. No published decision aid specific to PEMF was verified, so this is generic decision work. [uncertain: not verified; synthesis]
  • Steps:
    1. Clarify the decision and the deadline. Sales pressure often creates false urgency.
    2. List the options, including "wait", "trial before buying" and "ask my doctor first".
    3. For each option, explore expected benefits, costs (money, time, relationships), risks (the manufacturer's contraindications) and fit with the client's values.
    4. Check for pressure: who benefits if they say yes?
    5. Agree a review point, and record that the decision was the client's.
  • Example language (illustrative):
    • "If no one would be disappointed either way, which would you choose?"
    • "What would make you glad, a year from now, about how you decided?"
  • Watch for:
    • Deciding to please a seller-friend, or financing or debt.
    • Signs it is working: the decision is unhurried, the client can explain it, and the medical team knows.

4.5 Coordination with the client's doctor or pharmacist (with consent)

  • Purpose: make sure the medical team knows about the device, especially where the manufacturer's own warnings apply. That covers active implants, transplant with immunosuppression, DVT, pregnancy, uncontrolled seizures, severe heart-rhythm disorders, severe psychosis, tumour diseases and listed medicines (anticoagulants, antihypertensives, beta-blockers, high-dose corticosteroids, photosensitising medicines). [source: BEMER IFU Evo]
  • Steps:
    1. Explain why the doctor should know: the maker asks for medical approval in some situations, and only the doctor can judge them.
    2. Get written consent for what to share.
    3. Prefer client-led contact: help the client write down questions for their GP, cardiologist, device clinic, obstetrician or pharmacist.
    4. If you write yourself, keep to facts (device and brand, how it is used, the client's question). Make no recommendation.
    5. Never advise on starting, stopping or changing medicines. Route those questions to the prescriber.
    6. Follow up and record the outcome.
  • Example language (illustrative):
    • "The maker's own leaflet says people with a pacemaker shouldn't use it. Could we jot down a question for your heart clinic?"
    • "I can't advise on your tablets. Your pharmacist is the right person, and I'm happy to help you prepare the question."
  • Watch for:
    • Refusal to tell the doctor because of fear of judgement. Explore this rather than push.
    • Signs it is working: the client reports the doctor's view and the plan is shared.

4.6 Risk recognition and response

  • Purpose: spot situations where device use or the surrounding pressures could harm the client or others, and respond in proportion.
  • Risk signals and responses:
    • Delayed or stopped medical care: the client skips assessment for new, worsening or unexplained symptoms, or stops prescribed treatment. Raise it directly and encourage urgent medical contact. If capacity is in question, follow local capacity procedures.
    • Manufacturer contraindications: the client mentions a pacemaker or other active implant, a transplant with immunosuppression, or a diagnosed DVT. Name the leaflet warning and route the question to the treating team that day. [source: BEMER IFU Evo]
    • Pregnancy, uncontrolled epilepsy, severe heart-rhythm problems, severe psychosis: the manufacturer advises medical approval first. Prompt it. [source: BEMER IFU Evo]
    • Children: the US leaflet states use from 18. The Canadian leaflet allows use from 14, with supervision below that. [source: BEMER IFU Evo; US IFU copy, uncertain] Concern rises sharply if a child's medical care is replaced; follow safeguarding procedures in that case.
    • Financial exploitation and multi-level-marketing pressure:
      • Signs: large purchases, debt or financing; pressure to buy upgrades; being urged to recruit others or to "build a team"; income promises; loss of friendships when the client declines.
      • Response: explore the pressure openly, slow the decision, and consider debt advice or consumer-protection advice.
    • Group pressure: belonging, status or faith tied to the product. Explore what the client would lose by stepping back.
    • Psychosis or delusional content about electromagnetic fields: assess mental state and involve the psychiatric team as usual. The manufacturer also lists severe psychosis as needing medical approval. [source: BEMER IFU Evo]
  • Example language (illustrative):
    • "You mentioned you've put off the scan. Can we talk about what makes that hard?"
    • "It sounds like there's a lot of pressure to sign up others. How is that sitting with you?"
  • Watch for:
    • Secrecy, rising spending, and isolation from people who doubt the product.
    • Signs the response is working: medical care resumes and spending stabilises.

4.7 Managing conflicts of interest and the seller relationship

  • Purpose: keep therapy free of commerce. Use this when the client is a seller, is being recruited, invites you to a demonstration, or when a colleague or the practice offers the device. The sales route is a direct-sales and network-marketing structure built on sales partners. [source: ostjob.ch BEMER job listing] No ethics-code wording is cited for the professional ethics stance below. [synthesis; uncertain: not verified]
  • Steps:
    1. Decline any purchase, demonstration, referral fee or recruitment, warmly and clearly.
    2. If the client sells the device, explore what selling means to them: income, belonging, mission. Keep business out of sessions.
    3. If a colleague in your service offers or sells the device, raise it through supervision or clinical governance. Do not refer clients to them for the device.
    4. Record any declined offer and how you handled it.
  • Example language (illustrative):
    • "Thank you for thinking of me. I keep anything I buy or sell completely separate from therapy, so I'll say no, and that's no reflection on you."
    • "What does being part of the team give you?"
  • Watch for:
    • Repeated invitations, or a client who feels rejected when you decline.
    • Signs it is working: the boundary holds and the alliance survives.

4.8 Health anxiety, persistent somatic symptoms and environmental intolerance

  • Purpose: offer established psychological care when device use is part of a pattern of bodily preoccupation. The pattern may be:
    • repeated checking or symptom-focused buying;
    • persistent pain or fatigue with high distress;
    • fear of everyday electromagnetic fields (idiopathic environmental intolerance attributed to EMF).
    Use the approaches set out in Domain II (health anxiety and somatic symptom presentations). This entry does not restate them. [synthesis; cross-ref Domain II]
  • Steps:
    1. Map the cycle: trigger, bodily sensation, interpretation, device use or other safety behaviour, short-term relief, and continued worry.
    2. Validate that the symptoms are real and distressing.
    3. Agree a shared formulation and goals focused on function and quality of life.
    4. Apply the Domain II methods, for example:
      • cognitive work on threat appraisals;
      • reducing checking and reassurance-seeking;
      • graded return to activity;
      • attention training;
      • acceptance-based work with persistent pain.
    5. Treat device use as one possible safety behaviour to explore collaboratively, not something to ban. The client decides.
    6. Keep the medical team involved for new or changing symptoms.
  • Example language (illustrative):
    • "When the worry rises, what do you do next, and how long does the relief last?"
    • "What would you try if you trusted your body a little more?"
  • Watch for:
    • Escalating purchases or new "protective" products.
    • EMF fears spreading to avoidance of home, work or medical scans.
    • Signs it is working: wider activity, less checking, more flexible beliefs.

4.9 Review: tracking the effects of the device on life, money and care

  • Purpose: revisit the device at the review point the client chose. Look at its place in the client's life, not at whether it "works" physically.
  • Steps:
    1. Return to the client's own markers from 4.2.
    2. Ask about cost, time, relationships and medical contact since the last review.
    3. Explore disappointment, regret or embarrassment without blame.
    4. Re-open the decision if the client wishes (4.4).
  • Example language (illustrative):
    • "Last time you said you'd judge it by your walking. How has that gone?"
    • "It's OK if it hasn't been what you hoped. What's that like?"
  • Watch for:
    • Sunk-cost thinking, or shame about money spent.
    • Hopelessness if the device was a "last hope": screen mood and suicide risk using standard practice.
    • Signs it is working: the client makes a calm, owned judgement.

4.10 Reporting routes

  • Purpose: know where the client, or you with consent, can report device harms, misleading claims or sales practices.
  • Routes:
    • UK: adverse incidents with any medical device on the UK market can be reported by patients, the public and professionals through the MHRA Yellow Card scheme. In Scotland, device incidents in health facilities go through Health Facilities Scotland. [source: MHRA Yellow Card guidance]
    • US: device problems go to the FDA. The MedWatch route was not verified. [uncertain: not verified] Deceptive business practices, including MLM and pyramid concerns, go to the FTC at reportfraud.ftc.gov. [source: FTC consumer pages, MLM topic listing]
    • Advertising and consumer regulators elsewhere: e.g. the UK ASA, Health Canada, Australia's TGA and ACCC. [uncertain: not verified]
    • A professional providing it: misleading health claims or unsafe use by a regulated professional go to that professional's licensing board.
    • Safeguarding: a child or an adult at risk who is being deprived of medical care or financially exploited goes through local safeguarding procedures.
  • Steps:
    1. Discuss the option with the client.
    2. Help them gather facts: the product, the claims made, any harm, dates.
    3. Report with consent, except where safeguarding duties override it.
    4. Record the report.
  • Example language (illustrative): "If you think the claims you were given were misleading, there's an official route to report it. Would you like help with that?"
  • Watch for:
    • Fear of falling out with a seller-friend.
    • The report is made or declined by the client's informed choice.

5. Handling problems

All guidance in this section is the author's synthesis; the device facts are sourced as in 2a. [synthesis]

  • The client feels judged and goes quiet about the device:
    • Name the rupture: "I wonder if I sounded critical earlier."
    • Restate that the choice is theirs and that your interest is in them, not the product. Return to 4.2.
  • The client asks you to say whether it works, or to try it:
    • Decline to try or endorse it.
    • Offer the attributed facts (4.3) and ask what the answer would change for them.
  • The client wants you to tell their doctor it is fine:
    • Explain your scope.
    • Help them prepare questions for the doctor (4.5).
  • The client brings the device or a brochure to session, or offers a demonstration:
    • Decline kindly, and explore what they hoped you would see (4.7).
  • Stuck in debate: you notice yourself arguing about evidence. Stop and ask about the hope underneath, the time frame, and the client's own markers.
  • Non-adherence to medical care with high device reliance:
    • Treat this as the priority.
    • Explore the barriers: fear, distrust, past dismissal, cost.
    • Use motivational interviewing to address the ambivalence, and coordinate with the medical team (4.5, 4.6).
  • Implant or pregnancy discovered mid-therapy:
    • Name the manufacturer's warning without alarm.
    • Encourage same-day contact with the treating team. Document. [source for the warning: BEMER IFU Evo]
  • Financial crisis or debt after purchases or recruitment:
    • Address shame.
    • Refer to debt advice and consumer-protection routes, and consider safeguarding for an adult at risk (4.6, 4.10).
  • Family conflict:
    • A partner or relative is angry about spending, or the seller is a family member.
    • Consider a joint session focused on values and money rather than on whether the device works.
  • Overwhelm or catastrophic health fears:
    • Use grounding and pace the session.
    • Move to the Domain II health-anxiety formulation (4.8).
  • Psychotic or delusional EMF beliefs:
    • Do not debate them.
    • Assess risk and coordinate with psychiatric care.
  • Grief or regret after relying on the device during a missed diagnosis or a late treatment:
    • Work with guilt, anger at sellers, and self-blame.
    • Support any complaint the client chooses to make (4.10).
  • Gaps in the sources: none of the cited sources gives guidance for psychotherapists about PEMF devices. Everything in sections 4 and 5 beyond the device facts is the author's synthesis.

Sources

← Previous · XII-083Magnet therapy and copper braceletsNext · XII-085 →Consumer red-light and near-infrared panels